Annual Grant Award Dollars
| Investigator | Title | Sponsor | ID | Dates | Amount |
| James Patrick Bridges, PHD | Role of GPR116 in Alveolar Homeostasis | National Institutes of Health (NIH) | R01HL131634 | 3/1/2018 - 2/29/2020 | $398,105 |
| James Patrick Bridges, PHD | Development of Salisphere-derived systems for the study of cytomegalovirus vGPCR directed viral growth in the salivary gland | University of Cincinnati (National Institutes of Health (NIH)) | R21DE026267 | 9/1/2018 - 8/31/2019 | $10,929 |
| James Patrick Bridges, PHD | Mechanisms of vGPCR mediated Cytomegalovirus Growth in the Salivary Gland | University of Cincinnati (National Institutes of Health (NIH)) | R01AI121028 | 7/1/2018 - 6/30/2019 | $10,993 |
| Hitesh Deshmukh, MD-PHD | Development of neonatal innate lung defenses is dependent on gastrointestinal commensal bacteria | National Institutes of Health (NIH) | R01HL142708 | 9/1/2018 - 8/31/2019 | $417,649 |
| Hitesh Deshmukh, MD-PHD | Role of Microbiome in Neonatal Lung Maturation and Immune Susceptibility | The Regents of the Univ of California (National Institutes of Health (NIH)) | R01AI138553 | 3/19/2018 - 2/28/2019 | $96,198 |
| John J Erickson, MD-PHD | Maternal microchimerism transfer cellular immunity to offspring | American Academy of Pediatrics | 2018 Marshall Klaus | 7/1/2018 - 6/30/2019 | $5,000 |
| James M Greenberg, MD | Healthy Start Initiative-Eliminating Racial/Ethnic Disparities | Health Resources & Services Administration | H49MC27823 | 4/1/2018 - 3/31/2020 | $1,507,398 |
| Minzhe Guo | PCTC Administrative Coordinating Center | University of Maryland (Baltimore) (National Institutes of Health (NIH)) | U24HL134763 | 7/1/2018 - 5/31/2019 | $10,000 |
| Eric S Hall, PHD | Ohio Opioid Analytics Project | Ohio State University (Ohio Department of Medicaid (ODM)) | 1705OH5ADM | 7/1/2018 - 6/30/2019 | $81,140 |
| Lili He, PHD | Early Prediction of Cognitive Deficits in Very Preterm Infants using Machine Learning and Brain Connectome | National Institutes of Health (NIH) | R21HD094085 | 8/8/2018 - 7/31/2019 | $198,750 |
| Margaret K Hostetter, MD | Child Health Research Career Development Award (CHRCDA) Program (K12) | National Institutes of Health (NIH) | K12HD028827 | 12/1/2018 - 11/30/2019 | $459,000 |
| Tatiana Viktorovna Kalin, MD-PHD | Targeting Foxm1 in pulmonary fibrosis | National Institutes of Health (NIH) | R01HL132849 | 7/1/2018 - 6/30/2019 | $390,000 |
| Vladimir V Kalinichenko, MD-PHD | Transcriptional Regulation of Endothelial Cells after Acute Lung Injury | National Institutes of Health (NIH) | R01HL141174 | 4/1/2019 - 3/31/2020 | $524,323 |
| Beena Devi Kamath-Rayne, MD-PHD | Prediction of Fetal Maturity and Neonatal Morbidity Using Novel Biomarkers from Cell-Free Amniotic Fluid Transcriptome | National Institutes of Health (NIH) | R21HD096256 | 5/1/2019 - 4/30/2020 | $235,423 |
| Paul S Kingma Aaron Zorn, PHD James Wells, PHD |
Developmental Mechanisms of Trachea-Esophageal Birth Defects | National Institutes of Health (NIH) | P01HD093363 | 6/1/2018 - 5/31/2020 | $881,766 |
| Timothy D LeCras, PHD | Biomarkers and Pathogenesis of Lymphatic Anomalies | The Lymphatic Malformation Institute | Lecras, T., LMI | 5/1/2019 - 4/30/2020 | $175,935 |
| Timothy D LeCras, PHD | Characterizing the Formation and Function of Bone Lymphatics | The University of Texas Southwestern (National Institutes of Health (NIH)) | R01HL144793 | 1/10/2019 - 12/31/2019 | $34,710 |
| Stephanie L Merhar, MD | Cincinnati Center for Clinical and Translational Sciences and Training: Early Prediction of Motor Outcomes in Neonatal Encephalopathy and Stroke | University of Cincinnati (National Institutes of Health (NIH)) | KL2TR001426 | 4/1/2018 - 3/31/2019 | $162,450 |
| Louis Muglia | MoD Prematurity Research Center Ohio Collaborative Year | March of Dimes National | #22-FY18-811 | 1/1/2018 - 6/30/2019 | $1,000,000 |
| Louis Muglia | MoD PRC Ohio Collaborative Renewal | March of Dimes National | #22-FY18-824 | 10/1/2018 - 9/30/2019 | $500,000 |
| Nehal A Parikh DO | A New Model to Identify Preterm Neonates at High-Risk for Cognitive Deficits | National Institutes of Health (NIH) | R01NS094200 | 2/1/2019 - 1/31/2020 | $426,013 |
| Nehal A Parikh DO | Early Prediction of Cerebral Palsy in Premature Infants using Advanced MRI Biomarkers | National Institutes of Health (NIH) | R01NS096037 | 6/1/2019 - 5/31/2020 | $366,277 |
| Anne Karina Perl, PHD | Interstitial resident fibroblasts direct alveolar epithelial differentiation | National Institutes of Health (NIH) | R01HL131661 | 12/1/2017 - 11/30/2019 | $485,363 |
| Anne Karina Perl, PHD | Identification and Validation of New Biomarkers Based on Single Cell Rnaseq Data | The LAM Foundation | LAM0131PB07-18 | 9/1/2018 - 8/31/2019 | $8,662 |
| Anne Karina Perl, PHD | LAM cells Reprogram the Epithelial-Mesenchymal Crosstalk in the Alveolar Niche | The LAM Foundation | LAM0138E01-19 | 1/15/2019 - 1/14/2020 | $66,666 |
| Brenda Poindexter, MD-MS | NICHD Cooperative Multicenter Neonatal Research Network | National Institutes of Health (NIH) | UG1HD027853 | 4/1/2019 - 3/31/2020 | $274,808 |
| Brenda Poindexter, MD-MS | High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC | The Regents of the Univ of California (National Institutes of Health (NIH)) | U01NS092764 | 7/1/2018 - 6/30/2019 | $26,676 |
| Brenda Poindexter, MD-MS | The University of Rochester's Clinical and Translational Science Institute | University of Rochester (National Institutes of Health (NIH)) | UL1TR002001 | 6/1/2018 - 5/31/2019 | $12,942 |
| Brenda Poindexter, MD-MS | 1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center | Children's Hospital of Philadelphia (National Institutes of Health (NIH)) | UH3HL137872 | 9/1/2018 - 8/31/2019 | $39,877 |
| Brenda Poindexter, MD-MS | Developmental Impact of NICU Exposures (DINE) | Albert Einstein College of Medicine (National Institutes of Health (NIH)) | UH3OD023320 | 9/1/2018 - 8/31/2019 | $207,050 |
| Brenda Poindexter, MD-MS | HEAL - EEG - Neurophysiologic measures of Epo treatment for hypoxic-ischemic encephalopathy (HIE) | The Regents of the Univ of California (National Institutes of Health (NIH)) | R01NS104322 | 9/30/2018 - 6/30/2019 | $12,521 |
| Kurt Schibler, MD | Darbepoetin Trial to Improve Red Cell Mass and Neurodevelopment in Preterms | University of New Mexico (National Institutes of Health (NIH)) | R01HL136318 | 6/1/2018 - 5/31/2019 | $54,141 |
| Debora Ines Sinner, PHD | Molecular mechanisms underlying trachea formation and the pathology of tracheomalacia and complete tracheal rings | National Institutes of Health (NIH) | R01HL44774 | 4/4/2019 - 3/31/2020 | $419,805 |
| Kristen Suhrie, MD | Precision Medicine in the Diagnosis of Genetic Disorders in Neonates | Tufts Medical Center (National Institutes of Health (NIH)) | U01TR002271 | 8/15/2018 - 7/31/2019 | $69,490 |
| Takuji Suzuki, PHD | Genome edited iPS cell-derived macrophages as a novel lung cell therapy | National Institutes of Health (NIH) | R01HL136721 | 2/1/2018 - 1/31/2020 | $397,800 |
| Daniel Todd Swarr, MD | The role of the long non-coding RNA Falcor in early endoderm and lung development | National Institutes of Health (NIH) | K08HL130666 | 12/1/2018 - 11/30/2019 | $162,540 |
| Bruce C Trapnell, MD | RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases | National Institutes of Health (NIH) | U54HL127672 | 8/1/2018 - 7/31/2020 | $625,000 |
| Bruce C Trapnell, MD | Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP | National Institutes of Health (NIH) | R01HL085453 | 5/1/2019 - 4/30/2020 | $390,000 |
| Bruce C Trapnell, MD | Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trail (MILED) | University of Cincinnati (National Institutes of Health (NIH)) | U01HL131755 | 7/1/2018 - 6/30/2019 | $66,367 |
| Bruce C Trapnell, MD | Pulmonary Macrophage Transplantation for Pulmonary Alveolar Proteinosis | National Institutes of Health (NIH) | R01HL118342 | 7/1/2018 - 6/30/2019 | $505,189 |
| Bruce C Trapnell, MD | The 2018 International Rare Lung Diseases Clinical Research Conference | National Institutes of Health (NIH) | R13HL144006 | 8/1/2018 - 7/31/2019 | $40,000 |
| Timothy E Weaver, PHD | Deficiency of Phospholipid Transfer Protein, a driver of allergic airway disease | National Institutes of Health (NIH) | R01HL134186 | 6/1/2019 - 5/31/2020 | $495,373 |
| Scott Lewis Wexelblatt, MD | Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network "MOMS Developing Research protocol/Providing expertise for Implementing CTN Trial | University of Cincinnati (National Institutes of Health (NIH)) | 009942-023 | 6/1/2018 - 5/31/2019 | $19,068 |
| Jeffrey A Whitsett, MD Bruce C Trapnell, MD |
Lung and Cardiovascular Development and Disease Pathogenesis Training Program | National Institutes of Health (NIH) | T32HL007752 | 7/1/2018 - 6/30/2019 | $71,755 |
| Jeffrey A Whitsett, MD | Molecular Atlas of Lung Development - Data Coordinating Center | Duke University (National Institutes of Health (NIH)) | U01HL122638 | 5/1/2018 - 4/30/2019 | $132,559 |
| Jeffrey A Whitsett, MD | Editing Alveolar Progenitor Cells for Correction of Monogenic Disease | National Institutes of Health (NIH) | U01HL134745 | 6/1/2019 - 5/31/2020 | $1,274,477 |
| Jeffrey A Whitsett, MD Xinhua Lin |
Role of EMC3/TMEM111 in Alveolar Epithelial Cell Function | National Institutes of Health (NIH) | R01HL136722 | 4/1/2018 - 3/31/2020 | $275,040 |
| Jeffrey A Whitsett, MD Anjaparavanda Naren, PHD John Paul Clancy, MD |
Personalized Cystic Fibrosis Therapy and Research Center | National Institutes of Health (NIH) | P30DK117467 | 8/1/2018 - 6/30/2019 | $391,427 |
| Yan Xu, PHD | A Single cell mapping of nasal epithelial cells from CF vs. non-CF patients | Cystic Fibrosis Foundation | XU18A0-I | 4/1/2018 - 3/31/2020 | $108,000 |
| William John Zacharias, MD-PHD | Mechanistic evaluation of a novel Wnt-responsive adult alveolar epithelial progenitor population during regeneration after diffuse alveolar damage | National Institutes of Health (NIH) | K08HL140178 | 7/21/2018 - 6/30/2019 | $163,080 |
| Current Year Direct | $14,687,735 | ||||
Annual Industry Award Dollars
| Investigator | Industry Sponsor | Amount |
| Alan Hall Jobe, MD-PHD | Chiesi Farmaceutici S.P.A | $147,820 |
| Scott Lewis Wexelblatt, MD | Chiesi Farmaceutici S.P.A | $665,658 |
| Total Annual Industry Award Dollars | $813,478 | |
